Skip to main content
Equibles

Keith Murphy

Board Member

Matinas BioPharma Holdings, Inc. (MTNB)

Board Member

TuHURA Biosciences, Inc./NV (HURA)

Chairman

VivoSim Labs, INC. (VIVS)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Keith Murphy

Keith Murphy is recorded as Board Member at Matinas BioPharma Holdings, Inc. (MTNB), Board Member at TuHURA Biosciences, Inc./NV (HURA) and Chairman at VivoSim Labs, INC. (VIVS). VivoSim Labs, INC. reported in an 8-K filed October 6, 2026 that Keith Murphy was appointed Class III director, effective September 30, 2026. Matinas BioPharma Holdings, Inc. reported in an 8-K filed June 23, 2025 that Keith Murphy was appointed Director, effective June 23, 2025. Matinas BioPharma Holdings, Inc. reported in an 8-K filed March 11, 2025 that Keith Murphy was appointed directors of the Company, effective March 11, 2025. Equibles holds 4 filed executive changes naming Keith Murphy; each is listed under recent activity with its source filing. The proxy statement of VivoSim Labs, INC. reports total compensation of $865,961 for Keith Murphy in fiscal 2026, including a base salary of $740,210. Disclosed compensation is on record for 6 fiscal years. Keith Murphy has spoken on 7 earnings calls across 1 company, most recently on October 29, 2025.

“The Company’s stockholders elected Keith Murphy and Adam Stern as Class III directors, each to hold office until the 2029 Annual Meeting of Stockholders and until his respective successor is elected and qualified.”
VivoSim Labs, INC. Form 8-K, filed October 6, 2026 · Read the filing
“The stockholders elected the following individuals to serve on the Board until the annual meeting of shareholders to be held in 2026 and until their respective successors shall have been duly elected and qualified.”
Matinas BioPharma Holdings, Inc. Form 8-K, filed June 23, 2025 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Company

Current role
7 appearances Latest appearance 2025-10-29

Leadership on record at Matinas BioPharma Holdings, Inc.

Other people whose current roles at this company are on record from its filings.

Leadership on record at TuHURA Biosciences, Inc./NV

Other people whose current roles at this company are on record from its filings.

Leadership on record at VivoSim Labs, INC.

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2026 VivoSim Labs, INC. (VIVS) $740,210 $865,961
2025 VivoSim Labs, INC. (VIVS) $726,674 $1,165,657
2024 VivoSim Labs, INC. (VIVS) $657,984 $681,136
2023 VivoSim Labs, INC. (VIVS) $543,781 $621,448
2022 VivoSim Labs, INC. (VIVS) $430,073 $1,260,144
2021 VivoSim Labs, INC. (VIVS) $354,080 $2,360,645

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.